Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Elenkov, I. J., Wilder, R. L., Chrousos, G. P., & Vizi, E. S. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01470-4 · Cited by 2,252
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · cited 1×
“A study involving patients suffering from treatment resistant depression who received three infusions of the TNFa antagonist, infliximab indicated that this strategy although it is not effective in all circumstances, may improve depressive symptoms in patients with higher baseline inflammatory biomarkers (Raison et al…”
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278 · cited 2×
“Similarly, IDO activation has been shown to mediate LPS-driven depressive-like behaviours in rodents, with these behaviours being abolished by use of the IDO inhibitor, 1-methyl tryptophan (L) (O'Connor et al., 2009; Lawson et al., 2013).”
Pacher, P., Nivorozhkin, A., & Szabó, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.6 · Cited by 1,218
Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
The macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931 · cited 1×
“A role for inflammation in the pathogenesis of depression was originally put forward by Smith (1991) who developed the macrophage theory of depression in which he emphasised that it was the excessive secretion of cytokines from macrophages which bring about depression.”
Sauve, A. A., Wolberger, C., Schramm, V. L., & Boeke, J. D. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133500 · Cited by 763 · cited 2×
“For one, it is of utmost importance in the generation of energy (Berger et al., 1986), as well as being involved in the regulation of intracellular calcium and gene expression (Berger et al., 2004; Sauve et al., 2006).”
Agudelo, L. Z., Femenía, T., Orhan, F., Porsmyr-Palmertz, M., Goiny, M., Martinez-Redondo, V., Correia, J. C., Izadi, M., Bhat, M., Schuppe-Koistinen, I., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.051 · Cited by 739
Neuroinflammation and psychiatric illness
Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-43 · Cited by 733
Maes, M., Leonard, B. E., Myint, A. M., Kubera, M., & Verkerk, R. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.017 · Cited by 700
Chiba, S., Numakawa, T., Ninomiya, M., Richards, M. C., Wakabayashi, C., & Kunugi, H. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.05.018 · Cited by 673 · cited 1×
“Chronic stress has been reported to be accompanied by increased circulating glucocorticoids and resistance to glucocorticoids in both humans and animal models of stress (Miller et al., 2008; Chiba et al., 2012).”
Kynurenines in the CNS: recent advances and new questions
Vécsei, L., Szalárdy, L., Fülöp, F., & Toldi, J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3793 · Cited by 641 · cited 8×
“TDO is a homotetrameric enzyme with its expression primarily restricted to the liver in the periphery (Stone, 1993) while it is egulation of the kynurenine pathway: Relevance to neuropsychiatric g/10.1016/j.neuropharm.2015.12.004 Tryptophan Kynurenine 3-Hydroxykynurenine Quinolinic acid IDO KMO KYNU 3-Hydroxyanthranil…”
InfluentialRaison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J., Vogt, G., Spivey, J. R., Saito, K., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.116 · Cited by 630 · cited 2×
“Increases in the concentrations of kynurenine, quinolinic acid and KYNA have been identified in the cerebrospinal fluid (Raison et al., 2010), while decreases in plasma KYNA concentrations have also been reported in depressed patients (Myint et al., 2007).”
Quinolinic acid, the inescapable neurotoxin
Guillemin, G. J. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08485.x · Cited by 595 · cited 3×
“Moreover various KP metabolites are capable of producing free radicals and driving oxidative stress which is an additional putative contributing factor to ALS (Chen and Guillemin, 2012).”
Increased cortical kynurenate content in schizophrenia
Schwarcz, R., Rassoulpour, A., Wu, H.-Q., Medoff, D., Tamminga, C. A., & Roberts, R. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01078-2 · Cited by 590
Miller, G. E., Chen, E., Sze, J., Marin, T., Arevalo, J. M. G., Doll, R., Ma, R., & Cole, S. W. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.017 · Cited by 552 · cited 1×
“Chronic stress has been reported to be accompanied by increased circulating glucocorticoids and resistance to glucocorticoids in both humans and animal models of stress (Miller et al., 2008; Chiba et al., 2012).”
Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.014 · Cited by 544 · cited 2×
“Activation of oxidative and nitrosative pathways, and impairments in mitochondrial function are widely reported to be involved in the pathology of neurodegenerative and neuropsychiatric disorders (Glass et al., 2010; Maes, 2011; Federico et al., 2012; Muller, 2013).”
Guillemin, G. J., Smythe, G., Takikawa, O., & Brew, B. J. (2005) · Glia · doi:10.1002/glia.20090 · Cited by 497 · cited 1×
“The concentrations of quinolinic acid in the human brain are usually less than 100 nM but these can increase drastically in inflamed tissues (Guillemin et al., 2005a; Guillemin and Brew, 2002; Guidetti and Schwarcz, 2003).”
The new life of a centenarian: signalling functions of NAD(P)
Berger, F. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.01.007 · Cited by 489
Anxiety disorders and inflammation in a large adult cohort
Vogelzangs, N., Beekman, A. T. F., de Jonge, P., & Penninx, B. W. J. H. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.27 · Cited by 458 · cited 1×
“Men suffering from generalised anxiety disorder and panic disorder have been reported to exhibit raised circulating concentrations of C-reactive protein (Vogelzangs et al., 2013).”
Webster, M. J., Knable, M. B., O'Grady, J., Orthmann, J., & Weickert, C. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001139 · Cited by 420 · cited 1×
“Reductions in the levels of GR expressionwere found in the post mortem brains of patients with major depression, bipolar disorder and schizophrenia, indicating altered GR functioning (Webster et al., 2002).”
Quinolinic acid: an endogenous neurotoxin with multiple targets
Lugo-Huitrón, R., Ugalde Muñiz, P., Pineda, B., Pedraza-Chaverrí, J., Ríos, C., & Pérez-de la Cruz, V. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/104024 · Cited by 394
Lopresti, A. L., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.017 · Cited by 371
The kynurenine pathway and neurodegenerative disease
Maddison, D. C., & Giorgini, F. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.002 · Cited by 309 · cited 3×
“…cancer (http:// clinicaltrials.gov/show/NCT01191216), while KMO and KAT II inhibitors are under investigation for the treatment of neurodegenerative and cognitive disorders respectively [see, Bohar et al. (2015), Dounay et al. (2015), Maddison and Giorgini (2015), Amaral et al. (2013) for review].”
Social stress induces glucocorticoid resistance in macrophages
Stark, J. L., Avitsur, R., Padgett, D. A., Campbell, K. A., Beck, F. M., & Sheridan, J. F. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.6.r1799 · Cited by 295 · cited 1×
“GR resistance involves the reduced sensitivity of immune cells to glucocorticoids which would otherwise regulate the inflammatory response system (Stark et al., 2001; Marques et al., 2009).”
Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis
Myint, A.-M., & Kim, Y.-K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.08.008 · Cited by 230
Behan, W. M. H., McDonald, M., Darlington, L. G., & Stone, T. W. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702940 · Cited by 225 · cited 5×
“This can occur through the conversion of xanthine dehydrogenase into xanthine oxidase - an enzyme responsible for the production of ROS, and also through stimulation of nitric oxide synthase (Forrest et al., 2004).”
InfluentialSpitzer, C., Barnow, S., Völzke, H., Wallaschofski, H., John, U., Freyberger, H. J., Löwe, B., & Grabe, H. J. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.06.002 · Cited by 205 · cited 1×
“Similarly, patients suffering from post-traumatic stress disorder (PTSD) showed increased inflammatory markers (Spitzer et al., 2010).”
Glucocorticoid hormones and early brain development in schizophrenia
Ph.D., J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00396-7 · Cited by 199 · cited 1×
“This re-programming of the HPA axis and associated blunted GR signalling in immune cells, is believed to be an important link between prenatal stress and risk of psychosis in later life (Koenig et al., 2002).”
Childhood stressful events, HPA axis and anxiety disorders
Faravelli, C. (2012) · World Journal of Psychiatry · doi:10.5498/wjp.v2.i1.13 · Cited by 198
Nikkheslat, N., Zunszain, P. A., Horowitz, M. A., Barbosa, I. G., Parker, J. A., Myint, A.-M., Schwarz, M. J., Tylee, A. T., Carvalho, L. A., & Pariante, C. M. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.02.002 · Cited by 147 · cited 1×
“The KP has been implicated in cardiovascular disease and stroke (Nikkheslat et al., 2015; Cuartero et al., 2014; Darlington et al., 2007).”
Maternal separation induces neuroinflammation and long-lasting emotional alterations in mice
Gracia-Rubio, I., Moscoso-Castro, M., Pozo, O. J., Marcos, J., Nadal, R., & Valverde, O. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.09.003 · Cited by 144 · cited 1×
“These studies involved the use of both male and female mice, and demonstrated that behavioural abnormalities were more severe in females than males (Gracia-Rubio et al., 2015).”
Exercise for Mood and Anxiety Disorders: The State-of-the Science
Powers, M. B., Asmundson, G. J. G., & Smits, J. A. J. (2015) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2015.1047286 · Cited by 49 · cited 1×
“There is a large body of literature demonstrating that exercise is effective in alleviating suffering from mood disorders [see, Powers et al. (2015) for review].”
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180
Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain
Gao, K., Mu, C.-L., Farzi, A., & Zhu, W.-Y. (2020) · Advances in Nutrition · doi:10.1093/advances/nmz127 · Cited by 1,029
Kynurenine pathway metabolism and the microbiota-gut-brain axis
Kennedy, P. J., Cryan, J. F., Dinan, T. G., & Clarke, G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.002 · Cited by 724
“IDO1 expression can be induced by the action of inflammatory cytokines, Interferon (IFN)-γ in particular, and TDO expression by glucocorticoids (O’Mahony et al., 2015).”
BackgroundInfluentialDiet and depression: Exploring the biological mechanisms of action
Marx, W., Lane, M., Hockey, M., Aslam, H., Berk, M., Walder, K., Borsini, A., Firth, J., Pariante, C. M., Berding, K., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00925-x · Cited by 685
Metadata
- Authors
- O'Farrell, K., & Harkin, A.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 112
- Issue
- Pt B
- Pages
- 307-323
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2192218028
- Cited by
- 164
- References
- 37
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.